Fertility preservation in 2026: Current Landscape in Europe and the United States for Children and Adolescents Undergoing Hematopoietic Stem Cell Transplantation - Recommendations on behalf of the Westhafen Intercontinental Group [0.03%]
2026年生育力保存：欧洲和美国造血干细胞移植儿童和青少年的现状——Westhafen国际工作组推荐意见
Andrea Jarisch,Seth J Rotz,Alessandro Cattoni et al.
Andrea Jarisch et al.
Advances in hematopoietic stem cell transplantation (HSCT) and other cellular therapies have continued to better the long-term outcomes for pediatric patients undergoing these treatments. However, treatment impacts on future fertility can h...
Research Letter- Immune Cell Profiling in Lymphoma Patients Treated with CAR-T Cell Therapy and Nivolumab [0.03%]
CAR-T细胞治疗和纳武利尤单抗治疗淋巴瘤患者的免疫细胞谱分析研究通讯
Anwar Khatib,Amir Grau,Odelia Amit et al.
Anwar Khatib et al.
Longitudinal Study of Late Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: A Long-Term Follow-up Study from the Chronic Graft-Versus-Host Disease Consortium [0.03%]
造血干细胞移植后迟发急性及慢性移植物抗宿主病的纵向研究：移植物抗宿主病联盟的长期随访研究
Joseph Pidala,Lynn Onstad,Paul Carpenter et al.
Joseph Pidala et al.
Late acute and chronic graft-versus-host disease (GVHD) contribute to morbidity and death after allogeneic hematopoietic cell transplantation (HCT). A prior national Chronic GVHD Consortium longitudinal study enrolled patients pre- or early...
Hypogammaglobulinemia at leukapheresis predicts delayed humoral immune reconstitution and increased risk of infections after CD19 CAR-T for B-cell lymphoma [0.03%]
CD19 CAR-T治疗B细胞淋巴瘤后低丙种球蛋白血症与迟发性体液免疫重建不全及感染风险增加有关
Tatsuro Hirao,Daisuke Kaji,Mika Kuno et al.
Tatsuro Hirao et al.
Background: Infectious complications account for approximately half of non-relapse mortality after chimeric antigen receptor T cell (CAR-T) therapy, yet the impact of pre-infusion humoral immunity on post-infusion immune ...
Outcomes of DPB1 Mismatch in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Time to Move Past Chromosome 6? [0.03%]
移植到供者DPB1不相容的儿科同种异体造血干细胞移植受者中的结局：是时候超越第6号染色体了吗？
Hamid Farajifard,Atieh Karimzadeh,Maryam Behfar et al.
Hamid Farajifard et al.
Background: Human leukocyte antigen (HLA) matching is central to successful allogeneic hematopoietic stem cell transplantation (Allo-HSCT), minimizing graft-versus-host disease (GvHD) and improving survival. While matchin...
Incidence of and Risk Factors for Delayed Engraftment after Post-Transplant Cyclophosphamide [0.03%]
移植后环磷酰胺后的迟发性植入及其危险因素的发病率
Lauren Scarpetti,Daniel E Schwartz,Weixing Huang et al.
Lauren Scarpetti et al.
Proposal for Diagnostic Criteria for Manifestations of Chronic Graft-versus-Host Disease in Peripheral Nervous System and Muscles [0.03%]
周围神经和肌肉慢性移植物抗宿主病诊断标准的制定建议
Tim Steinberg,Klemens Angstwurm,Matthias A Fante et al.
Tim Steinberg et al.
Background and objectives: Atypical neurological graft-versus-host disease (cGVHD) is a rare complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). In addition to central nervous system (CNS) i...
Factors Associated with Prolonged Inpatient Stay in Patients undergoing Outpatient Allogeneic Stem Cell Transplantation [0.03%]
影响门诊异基因干细胞移植患者住院时间延长的相关因素分析
Edward Koo,Connor Prince,David Allan et al.
Edward Koo et al.
Background: Allogeneic Hematopoietic stem cell transplantation (HCT) in the outpatient setting has been previously shown to be safe and feasible. However, there is paucity of data on the factors associated with prolonged ...
Long-term follow-up after mixed donor myeloid chimerism at 1 year post transplantation for sickle cell disease [0.03%]
接受移植治疗后的混合供者髓系嵌合体的长期随访结果（1年）-镰状细胞病患者
Gregory M T Guilcher,Stuti Dalal,Tara Suresh et al.
Gregory M T Guilcher et al.
Background: Hematopoietic cell transplantation (HCT) for sickle cell disease (SCD) is an established cure, but mixed donor chimerism is common even with myeloablative conditioning regimens. With many North American center...
Desensitization therapy using sirolimus and anti-CD20 monoclonal antibody based regimen in haploidentical transplant recipients positive for donor-specific anti-HLA antibodies [0.03%]
基于西罗莫司和抗CD20单克隆抗体方案治疗供者特异性人白细胞抗原抗体阳性单倍体相合移植受者的脱敏疗法
Ning Ma,Xiang-Yu Zhao,Lan-Ping Xu et al.
Ning Ma et al.
This retrospective study evaluated the efficacy of desensitization therapy using sirolimus and an anti-CD20 monoclonal antibody (n = 47) plus either plasmapheresis (n = 3) or bortezomib (n = 3) in 53 candidates for haploidentical stem cell ...